Pacira Pharmaceuticals (NASDAQ: PCRX) reported Q2 EPS of ($0.27), $0.16 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $8.77 million.

For earnings history and earnings-related data on Pacira Pharmaceuticals (PCRX) click here.

Earnings